IDEAYA trial extends progression-free survival to 6.9 months
IDEAYA Biosciences (NASDAQ:IDYA) said OptimUM-02 met its primary endpoint, extending median progression-free survival to 6.9 months from 3.1 months.

Crypto journalist for Grafa, with nearly 10 years of experience covering blockchain, Web3, and NFT gaming trends. MBA & Economics grad.
IDEAYA Biosciences (NASDAQ:IDYA) said OptimUM-02 met its primary endpoint, extending median progression-free survival to 6.9 months from 3.1 months.
Graphic Packaging (NYSE:GPK) reported second-quarter net sales of $2.188 billion, down 1%, while net income fell to $24 million.
Kimberly-Clark (NASDAQ:KMB) reported second-quarter net sales of $4.2 billion, up 0.6%, while adjusted operating profit rose 6.2% to $757 million.
Waters Corporation (NYSE:WAT) reported second-quarter revenue of $1.645 billion, including $828 million organically and $817 million from acquired businesses.
HSBC Holdings (NYSE:HSBC) reported second-quarter pretax profit of $10.1 billion, up 60%, and launched a $1 billion share buyback.
Wix (NASDAQ:WIX) reported a second-quarter 2026 revenue of $563.1 million, representing a 15% year-over-year increase.
NEAR Protocol (CRYPTO:NEAR) co-founder Illia Polosukhin proposed a 30 million NEAR sovereign fund worth about US$57 million.
Prediction market operator Kalshi faces at least US$36 billion in requested damages and penalties in a lawsuit filed by New York.
Aware Super and Prime Super signed an agreement to explore a merger, creating a $254 billion fund.
Communications software firm Etherstack (ASX:ESK) appointed US executive Ryan Burchnell, who brings 30 years of experience, as Group COO.